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Impact of dietary supplementation with olive and
thyme phenols on alpha-tocopherol concentration
in the muscle and liver of adult Wistar rats†
David Bars-Cortina, a María-Carmen López de las Hazas, a
Alfred Benavent-Vallésb and Maria-José Motilva *a
A preliminary study to evaluate the effect of dietary supplementation with olive phenols (oleuropein,
hydroxytyrosol and secoiridoids), thyme phenols and a combination of these (5 mg per kg rat weight per
day) on the α-tocopherol concentrations in the muscle and liver of healthy adult Wistar rats over 21 days
was conducted. In addition, the excretion of α-tocopherol through the faeces was examined. The results
demonstrated that the diet supplemented with some phenolic compounds of olive and thyme increased
α-tocopherol (P < 0.05) in the liver of female rats, although the α-tocopherol content in the diet of all
groups was identical. In addition, a synergic effect between the olive phenols and thyme was observed.
Therefore, our study indicates a protective effect of olive and thyme phenols supplemented in the diet on
α-tocopherol, resulting in a higher concentration of endogenous α-tocopherol in the rat liver.
1. Introduction
Vitamin E is an essential micronutrient in the diet of all
mammals. It acts as a potent antioxidant in biological
systems.1,2 It is the main chain-breaking antioxidant that pre-
vents the propagation of free radical reactions3 and their
damage to tissues, especially with polyunsaturated fatty acids
(PUFA), which are prone to oxidation.4 Consequently, supple-
menting animal feed with synthetic vitamin E is a convention-
al strategy for counteracting oxidative stress to decrease the
susceptibility to oxidation,1 which could affect livestock
adversely, especially under intensive breeding systems.5
Nevertheless, the trend is towards a decrease in the use of syn-
thetic feed additives given consumer concerns over health
safety and toxicity6,7 and due to the increasing consumer inter-
est in organic farming and more sustainable livestock pro-
duction,8 but also for emotional reasons.9 Consequently, the
search for natural antioxidants, especially from plants, has
intensified in recent years.7,10
It has been demonstrated in vitro that redox interactions of
different kinds of natural antioxidants, such as polyphenols,
are capable of regenerating oxidized α-tocopherol.11–15 In
addition, the vitamin E status affected by polyphenols has
also been evaluated in vivo, obtaining in some cases an
increase of α-tocopherol in tissues. In particular, red wine
polyphenols;16,17 flavonoids;18–21 green tea polyphenols22–24
anthocyanins25 and lignans26 have been the more studied
phytochemicals.
A more recent study, although not involving a long-term
dietary supplementation, showed that the direct incorpor-
ation of different concentrations of grape procyanidin powder
to the minced white muscle of fresh Atlantic horse mackerel
(Trauchurus trauchurus) repaired oxidized α-tocopherol in the
medium to long term.27 Another study found that long-term
dietary supplementation with a plant extract from Lippia spp.
(5 mg verbascoside per kg feed) in pigs for 166 days increased
α-tocopherol levels in the Longissimus dorsi muscle.10 The
plant extract added to the feed did not contain α-tocopherol,
but it was capable of increasing endogenous α-tocopherol,
compared with the control diet, indicating a protective effect
of verbascoside. With the same type of plant extract, but
when given to hares, a significant increase in α-tocopherol in
the Longissimus lumborum muscle has been observed.28
Therefore, these studies have shown the potential of some
phenolic compounds to regenerate α-tocopherol via one-elec-
tron reduction of α-tocopheroxyl radicals, which comp-
lements endogenous antioxidant systems such as ascorbate
and ubiquinol.29–31
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Based on this evidence, the main aim of the present study
was to check whether the sustained supplementation of the
diet of healthy Wistar rats with the most representative olive
phenols (oleuropein as a glucoside molecule, secoiridoids as
aglycone derivatives of oleuropein, and hydroxytyrosol (HT)),
thyme phenols and a combination of olive/thyme phenols
increased the α-tocopherol concentration in the muscle tissue
and in the liver in comparison with the control group that was
fed with the same amount of α-tocopherol but without olive
and thyme phenols. Olive and thyme phenols were chosen in
the study because they are basic elements in the Mediterranean
Diet.32 Although rat muscle is not a meat-based food, the
muscle has been studied because it is the tissue studied in the
mentioned literature.10,28 Furthermore, in the case of the exist-
ence of a protective effect of the diet supplementation with
phenols on the endogenous α-tocopherol in the liver, this fact
could open the way to another approach to the treatment of
some fatty liver diseases (e.g. NAFLD/NASH), where oxidative
stress is considered as one of the main players in their develop-
ment and progression33. However, this is not within the scope
of this study. Nowadays, there is no pharmacological treatment
for these liver diseases and treating them involves mainly
changes in lifestyle and diet.34 However, patients with NASH or
risk factors for NASH who fail to achieve a 5–10% weight
reduction over 6–12 months of successful lifestyle changes
could be apt candidates for an experimental therapy,35 the
most studied of which is the oral administration of vitamin E.
From the results of two large randomized human control
trials (the PIVENS and TONIC studies) analysing the effect of
vitamin E at high doses (≥400 IU day−1) in NASH patients, and
according to the meta-analysis conducted in ref. 33, vitamin E
significantly improves liver function and histological changes
in patients with NAFLD/NASH. Furthermore, in patients with
cirrhosis36 or chronic alcohol consumption (ASH),37 the level
of α-tocopherol in the liver decreased significantly, and thus
any strategy that increases the α-tocopherol in the liver is
interesting.
Furthermore, the biological metabolites of different olive
and thyme phenols were determined in the present study to
assess changes in their concentration in the muscle tissue and
liver related to the phenol diet supplementation. In addition,
the goal of combining secoiridoids (the main phenols in virgin
olive oil) with thyme phenols was to evaluate possible synergic
effects, as also studied by our colleagues,38 who discovered
that the presence of thyme jointly with olive phenols in the
diet enhances the bioavailability of olive phenolic compounds
in rat plasma. To the best of our knowledge, the potential pro-
tective effect of these particular phenolic compounds on
endogenous α-tocopherol has not been studied in vivo.
2. Materials and methods
2.1. Animals and experimental procedure
The animal procedures were conducted in accordance with the
guidelines of the EU Directive 2010/63/EU for animal experi-
ments and approved by the Animal Ethics Committee at the
University of Lleida (CEEA 10-06/14, 31st July 2014). Forty-eight
male and female Wistar rats weighing between 300–350 g were
obtained from Charles River Laboratories (Barcelona, Spain).
They were separated into six groups with 8 rats in each group
(4 males, 4 females): Control diet, Oleuropein (OLE),
Secoiridoids (SEC), Hydroxytyrosol (HT), Secoiridoids com-
bined with thyme phenols (SEC + T), and Thyme phenols (T)
(Table S1, ESI†). During the 21-day experiment, the animals
were housed two per cage in a temperature (21 ± 1 °C) and
humidity-controlled (55 ± 10%) room with a 12 h light/dark
cycle. Food and water were available ad libitum. The secoiri-
doid and thyme phenol extracts were obtained from an olive
cake and dried thyme (Thymus zygis), respectively. In both
cases, the phenolic extracts were obtained with an accelerated
solvent extractor (ASE 100 Dionex, Sunnyvale, CA) using the
method described in ref. 32. The phenolic extracts were ana-
lyzed by liquid chromatography (UPLC-MS/MS) in order to
determine the concentration of secoiridoids (expressed as the
dialdehydic form of elenolic acid linked with hydroxytyrosol,
3,4-DHPEA-EDA) in the case of the olive cake, and the concen-
tration of rosmarinic acid and the flavonoid thymusin, in the
case of thyme. Once these phenolic compounds had been
quantified, the extracts were mixed with the feed to prepare
the proposed dose.
For the supplemented diets, commercial feed pellets Teklad
Global 14% Protein Rodent Maintenance Diet (Harlan
Laboratories, Santa Perpètua de Mogoda, Spain) (specification
sheet in Fig. S1, ESI†) were crushed in an industrial mill and
mixed with Milli-Q water containing the equivalent of 5 mg of
phenols per kg rat weight in 16 g of crushed pellet (average
daily consumption per rat). New pellets were prepared and
freeze-dried. Food and animals were weighed every week for
2 days to adjust the weekly dose of the phenolic compound to
5 mg per kg rat weight per day. All treatments involved the
same daily dose of vitamin E (120 IU vitamin E per kg of feed),
which is included within the formula of the commercial feed
used (ESI Fig. S1†). On the twenty-first day, the rats were sacri-
ficed by intracardiac puncture after isoflurane anesthesia
(ISOFlo, Veterinaria Esteva, Bologna, Italy). External oblique
muscle (abdominal region) and liver samples were extracted.
The samples were frozen immediately in liquid nitrogen and
then stored at −80 °C until they were analyzed. Furthermore,
the faeces from the 21st day were collected.
2.2. Determination of α-tocopherol in muscle, liver and
faeces
The sample pre-treatment was based on the method proposed
in ref. 39 with modifications contingent on the reduction of
the acetone volume used in the extraction washes. In detail,
the method comprised the following steps: (i) lyophilization of
the samples (Lyophilizer TELSTAR Lyobeta 15, Terrassa,
Spain); (ii) the weighing of 100 mg of lyophilized sample; (iii)
homogenization in 5 mL of acetone (Scharlau, Sentmenat,
Spain) with a homogenizer (Polytron PT 1200 E, Kinematica,
Luzem, Switzerland) for 15 seconds; (iv) centrifugation of the
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homogenate at 3600 rpm for 10 minutes at 15 °C, and (v)
transfer of the supernatant to a new test tube. The pellet was
re-extracted two more times with 5 mL of acetone each time.
All the supernatant fractions were reduced to dryness under N2
(N2 LCMS Nitrogen Generator, Claind, Lenno, Italy; Reacti-Vap
model 18780, Rockford, USA). The residue was resuspended
with 1 mL of n-hexane 96% (Scharlau, Sentmenat, Spain) and
filtered with a 0.45 µm membrane filter (NYL1345200,
Scharlau, Sentmenat, Spain) and 20 µL was injected into the
HPLC system.
α-Tocopherol was analyzed by liquid chromatography
(HPLC) according to the method described in ref. 40. The
HPLC equipment consisted of a Waters 600 Controller pump,
Waters 717 plus Autosampler and Waters 2475 Multi λ
Fluorescence Detector (Waters Corporation, Milford,
Massachusetts, USA). A silica column was used (Luna® 5 µm
Silica C18(2) 100 Å 250 × 4.60 mm). The mobile phase was
hexane–isopropanol (99 : 1). Detection of α-tocopherol was con-
ducted through fluorescence analysis (λex: 295 nm/λem:
330 nm) and the quantification was based on the external cali-
bration curve. The recovery of α-tocopherol in the different
matrices studied was between the range 95–100%.
2.3. Sample pre-treatment for phenolic metabolite analysis
The muscle and liver samples were sequentially pretreated
with a combination of liquid–solid extraction (LSE) combined
with microelution solid-phase extraction (µSPE).41 Briefly, for
the analysis of LSE, 60 mg of freeze-dried samples was mixed
with 50 µL of ascorbic acid (1%), 100 µL of phosphoric acid
(4%), and 50 µL of catechol 20 ppm (as the internal standard).
The samples were treated four times with 400 µL of water/
methanol/phosphoric acid 4% (94 : 4.5 : 1.5, v/v/v). In each
extraction, the sample was sonicated for 30 s, maintaining it in
ice to avoid heating, and then centrifuged. The supernatants
were collected (approx. 1600 µL), and an aliquot of 350 µL of
the supernatant was diluted with 350 µL of phosphoric acid
4% (resulting volume: 700 µL, tissue mixture). This 700 µL was
used in the µSPE procedure described below. OASIS hydro-
philic–lipophilic balance (HLB) µElution plates 30 µm (Waters,
Milford, MA, USA) were used. The cartridges were conditioned
sequentially by using 250 µL of methanol and acidified Milli-Q
water (Milli-Q water at pH 2 with diluted hydrochloric acid).
After loading the tissue mixture (700 µL), the plates were
washed with 200 µL of Milli-Q water and 200 µL of 5% metha-
nol. The retained phenolic compounds were then eluted with
2 × 50 µL of methanol and injected into an UPLC-MS/MS
system.
2.4. Chromatographic analysis of phenolic compounds
The phenolic compounds were analysed by using an UPLC
system, coupled to a PDA detector, Acquity
Ultraperformance™ liquid chromatography and a triple quad-
rupole detector (TQD™) mass spectrometer from Waters
(Milford, MA, USA), as reported in our previous study.41 The
column was an Acquity UPLC™ HSST3 from Waters (100 mm,
2.1 mm i.d., 1.8 µm particle size). The mobile phase was 0.2%
(v/v) acetic acid as solvent A and methanol as solvent B, with a
flow rate of 0.4 mL min−1. The gradient was performed as
follows: 0–6 min, 3–15% B; 6–14 min, 15–70% B; 14–17 min,
70–100% B; 17–18 min, 100–3% B; 18–20 min, 3% B isocratic.
The injection volume was 2.5 µL. The software used was
MassLynx 4.1. Ionization was done by electrospray (ESI) in the
negative mode, and data were collected by selected reaction
monitoring (SRM). The MS/MS parameters were as follows:
capillary voltage, 3 kV; source temperature, 150 °C; cone gas
flow rate, 80 L h−1 and desolvation gas flow rate, 800 L h−1;
desolvation temperature, 400 °C. Nitrogen (>99% purity) and
argon (>99% purity) were used as the nebulizing and collision
gases, respectively. The SRM transitions, individual cone vol-
tages and collision energies were optimized for each analyte by
injection of each standard compound into a mixture of metha-
nol/water (1 : 1, v/v) at a concentration of 10 mg L−1. Two SRM
transitions were studied to find the most abundant product
ions, selecting the most sensitive transition for quantification
and the second one for identification purposes. When stan-
dard phenolic compounds were not available, the SRM para-
meters were selected by analyzing the real sample in full-scan
mode in MS and in daughter-scan mode in tandem MS. When
standard compounds were not available, the phenolic com-
pound was tentatively quantified with a phenol standard with
a similar chemical structure. The chromatographic analysis for
the metabolites derived from thyme was performed according
to our previous study.32
2.5. Statistical analysis
IBM SPSS Statistics software v.20 was used for the statistical
analysis with a level of significance set at 95%. The normality
of the data was evaluated according to the Shapiro–Wilk test.
In the case of normal data a one-way ANOVA test was per-
formed followed by a Tukey or Games-Howell post-hoc test in
the case of ANOVA significance. In the case of non-normal
data the Kruskal–Wallis test was performed and the Dunn-
Bonferroni post-hoc test was performed in the case of Kruskal–
Wallis test significance.
3. Results and discussion
Table 1 summarizes the animal performance including the
body weight, feed intake and liver weight reported according
to diet treatment and gender. For each gender, no statistical
significant differences were detected between the control
group and any of the treatments. In addition, no animal
suffered from any disease or even died.
3.1. α-Tocopherol content in the liver
The absorption of vitamin E from the intestinal lumen is
dependent upon processes necessary for digestion of dietary
fats and uptake into enterocytes. Vitamin E absorption
requires the presence of bile acids for micelle formation. In
addition, vitamin E needs pancreatic enzymes for its lipid
hydrolysis to aid in the absorption of vitamin E in entero-
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cytes.42 In the intestinal mucosa, chylomicrons are formed as
vehicles for transport, consisting of triglycerides, free and
esterified cholesterol, carotenoids, phospholipids, proteins
and apolipoproteins (apoB48) and fat soluble vitamins (includ-
ing vitamin E).43 Chylomicrons are catabolized in the circula-
tion by the endothelial-bound lipoprotein lipase enzyme.
Chylomicron catabolism leads to some transfer of vitamin E to
tissues (i.e. muscle tissue, discussed below). After partial deli-
pidation (due to lipoprotein lipase) and acquisition of apoE,
chylomicron remnants are taken up by the liver parenchymal
cells. These remnants taken up by the liver likely contain a
major portion of absorbed tocopherols.42
No organ (and the liver is not an exception) functions as
storage of α-tocopherol. In the liver, newly absorbed dietary
lipids are incorporated into nascent very low density lipopro-
teins (VLDL) enriched preferentially in RRR-α-tocopherol due
to the hepatic cytosolic α-tocopherol transfer protein (α-TTP).
RRR-α-tocopherol is the naturally occurring stereoisomer with
the highest biological activity, being the main form of vitamin
E in humans due to its physicochemical and biological charac-
teristics (i.e. α-tocopherol provides optimal structural inter-
actions with the membrane phospholipids). A number of
studies have supported that the liver is responsible for the
control and release of RRR-α-tocopherol into human plasma,
and therefore to the peripheral tissues.43,44
As we have now briefly described the tocopherol absorption
and transport to the liver, let’s comment on the liver
α-tocopherol content detected in our study. No significant
differences between treatments in the mean concentration of
α-tocopherol in the liver (combined sexes) (μg g−1 liver) were
seen (Fig. 1). Nevertheless, by analyzing the results according
to rat gender (Fig. 1) an important sexual dimorphism was
detected. We observed that the diet supplementation with the
particular olive phenols (OLE and HT) and the combination of
these with thyme phenols (SEC + T), produced an increase of
the α-tocopherol concentration in the female liver compared
with the control (P < 0.05). This finding is well-established in
the literature.45–48 Comparing our results with the literature
available, we have only found studies on male rodents which,
depending on the polyphenol studied, showed a significant
increase in α-tocopherol liver concentration18,20,25,26 or
not21,22,49 in comparison with the control group.
Finally, in this section, although it is not within the scope
of our study, we considered it adequate to mention briefly fatty
liver diseases (e.g. NAFLD/NASH). The mechanisms leading to
hepatic steatosis and subsequently NASH have remained
Table 1 Animal performance (mean ± standard deviation) according to diet treatment and rat gender
Parameter
Control HT SEC OLE SEC + T T
♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀
Body weight
(g)
426 ± 27 395 ± 25 437 ± 19 384 ± 22 438 ± 10 388 ± 22 411 ± 31.9 395 ± 6.3 422 ± 26 387 ± 26 441 ± 27 394 ± 35
Feed intake
(g daily)
18.7 ± 1.2 14.3 ± 1.2 18.1 ± 1.3 14.0 ± 0.9 17.9 ± 0.8 14.1 ± 1.2 17.8 ± 0.5 14.4 ± 0.8 18.5 ± 0.5 14.7 ± 0.5 18.1 ± 0.8 13.8 ± 0.2
Liver weight
(g)
8.4 ± 1.5 7.1 ± 1.1 7.6 ± 0.8 7.3 ± 0.7 8.9 ± 1.7 7.1 ± 1.0 7.1 ± 0.8 6.7 ± 0.8 9.4 ± 2.4 7.0 ± 0.4 11.1 ± 1.0 7.6 ± 0.3
♂: male; ♀: female; HT (hydroxytyrosol), SEC (secoiridoids), OLE (oleuropein), SEC + T (secoiridoids + thyme), T (thyme).
Fig. 1 Total α-tocopherol in the liver for each treatment, separated by gender for each treatment (mean ± SD). C (control), OLE (oleuropein),
SEC (secoiridoids), HT (hydroxytyrosol), SEC + T (secoiridoids + thyme), T (thyme). Statistically significant differences by gender for each treatment:
***(P < 0.01). Statistically significant differences by treatment compared to the control: ‡(P < 0.05), ‡‡(P < 0.025), ‡‡‡(P < 0.01).
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poorly understood, but are often characterized by a “two-hit
mechanism”.50 The “first-hit”, triggered by obesity and insulin
resistance, results in excess hepatic lipid accumulation
causing hepatic steatosis and injury. Steatotic livers are vulner-
able to suffer “second-hits”, mediated by inflammation and/or
oxidative stress, resulting in NASH. Elevated oral doses of
vitamin E have been used to treat these liver pathologies in
humans but its results and safety are controversial.51
Nevertheless, a study52 in an obese mouse model with induced
NASH episode through LPS (lipopolysaccharides) action
demonstrated that the hepatic accumulation of α-tocopherol
mitigates the liver damage produced by NASH. In addition, in
patients with cirrhosis36 or chronic alcohol consumption
(ASH),37 the level of α-tocopherol in the liver decreased signifi-
cantly, and thus any strategy to increase the α-tocopherol in
the liver is interesting.
3.2. α-Tocopherol content in muscle tissue
The muscle tissue ( jointly with the brain) has a low vitamin E
turnover in contrast to the fast turnover in plasma or in liver
tissue. There are no specific transport proteins for vitamin E
in plasma, and consequently lipoproteins are mainly respon-
sible for the vitamin E transport. Therefore the major mecha-
nisms for the delivery of vitamin E to tissues are also the
major mechanisms for the delivery of lipids to the tissues.43
Additionally, vitamin E delivery to tissues can also take place
via the LDL receptor. Nevertheless, muscle tissue, which
receives most of their analys during the delipidation cascade,
probably obtains tocopherols mainly as a result of lipoprotein
lipase activity43 commented above.
In the present study, the mean concentration of
α-tocopherol in the muscle (combined sexes) (μg g−1 muscle)
showed no significant differences between treatments (Fig. 2),
although dietary supplementation with SEC + T and T resulted
in a higher concentration of α-tocopherol in rat muscle. When
the concentration of α-tocopherol in the muscle was analysed
according to the gender (Fig. 2), no significant differences
were detected except in the HT and SEC groups for males and
females respectively, where the concentrations of α-tocopherol
were lower than in the control group. These results are not in
agreement with two previous studies that detected an increase
in the concentration of α-tocopherol in the muscle after long-
term dietary supplementation with a plant extract titrated in
verbascoside in hares (240 days)28 and pigs (166 days)10. Our
first hypothesis is that 21 days of diet supplementation with
phenols may not be long enough to produce a significant
increase in the α-tocopherol concentration in the muscle. For
example, one study53 in growing pigs did not establish differ-
ences of α-tocopherol muscle concentration in response to
green tea polyphenols added to the diet over a 35 day period.
Nevertheless, in our study to explain the lack of differences in
α-tocopherol muscle concentration, a plausible reason could
be the composition of the rat muscle fibre. Alpha-tocopherol is
deposited in greater amounts in skeletal muscles rich in fibre
types with high oxidative capacity (fibres type I, red/slow
muscle) than in muscle fibre types with low oxidative capacity
(fibres type II, white/fast muscle).54 Rat muscle is character-
ized by a low proportion of type I fibres, approximately only
6%.55 Additionally, the characteristics of the rat muscle (low
intramuscular fat) in relation to hare or pig muscle could
explain the results observed in our study that showed no stat-
istical differences in the α-tocopherol deposition in rat muscle
in relation to dietary phenol supplementation.
3.3. α-Tocopherol content in faeces
The main route for eliminating α-tocopherol from the body
is through faeces, mainly as a result of incomplete intesti-
nal absorption. Secretion from mucosal cells, desquama-
tion and biliary excretion also contribute to faecal
α-tocopherol.56,57 In order to assess whether the higher con-
centration of α-tocopherol in the liver in some treatments
(Fig. 1) could be related to greater efficiency in the absorp-
tion of dietary α-tocopherol, the rat faeces were studied.
The results of the analysis of the α-tocopherol content in
the faeces for each treatment as group means (combined
sexes) or separated by gender are shown in Fig. 3. Analyzing
Fig. 2 Total α-tocopherol in muscle tissue for each treatment, separated by gender for each treatment (mean ± SD). C (control), OLE (oleuropein),
SEC (secoiridoids), HT (hydroxytyrosol), SEC + T (secoiridoids + thyme), T (thyme). Statistically significant differences by gender for each treatment:
**(P < 0.025), ***(P < 0.01). Statistically significant differences by treatment compared to the control: ‡(P < 0.05).
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the global data, some treatments (SEC, SEC + T and T) pro-
duced a significant increase in the α-tocopherol concen-
tration in the faeces compared with the control group.
Nevertheless, the HT group showed no significant increase
in the α-tocopherol content in the faeces compared with the
control, even though this group showed a significant
increase in the α-tocopherol concentration in the liver
(Fig. 1). It is noteworthy that the SEC + T group showed a
high concentration of α-tocopherol in the liver (Fig. 1) and
the highest in faeces (Fig. 3) compared with the control
group. A tendency was observed regarding sexual dimorph-
ism (Fig. 3). In general, the α-tocopherol content in the
faeces of the male rats was higher than in the faeces of the
females, but only the HT group showed significant differ-
ences (P < 0.01). So, the higher excretion of α-tocopherol in
male faeces could partially explain the lower concentration
of α-tocopherol observed in the male livers (Fig. 1).
3.4. Plausible synergy between secoiridoids and thyme in
α-tocopherol
From the SEC + T group statistical significance in the vitamin
E concentration in female rat livers and its almost statistical
significance in muscle tissue, it seems possible that an
enhanced bioavailability of α-tocopherol could occur in the
presence of thyme. These results are in the same line as the
synergic findings reported in ref. 38 which detected an
increase of olive phenolic compounds’ bioavailability in rat
plasma due to the presence of thyme in the diet containing
olive phenolic compounds.
3.5. Phenolic compounds
There are a number of processes occurring during vitamin E
absorption, metabolism and trafficking that could be targeted
by phenolics. One mechanism could be the interaction with
mixed micelle formation in the small intestine, where the
more abundant lipid-soluble phenolics may compete with the
incorporation into micelles and the uptake of vitamin E into
enterocytes. Nevertheless, some studies suggested that olive
phenolic compounds are absorbed from the intestine not
through a pathway dependent on the chylomicron formation.58
While the more simple phenolic compounds, such as phenolic
acids, can cross the cell membrane via passive diffusion, more
complex phenolic compounds, such as flavonoid glycosides,
cross the enterocyte cell membrane via two active mechanisms:
lactase-phlorizin hydrolase (LPH) or active sodium-dependent
glucose transporter (SGLT1).59 Another mechanism could be
the competition between phenolic compounds and vitamin E
in the liver during the phase II metabolism. Nevertheless, phe-
nolic compounds unlike vitamin E undergo phase II metab-
olism not only in the liver but also in the enterocyte cytosol.59
Finally, another relevant mechanism could be the influence of
phenolic compounds on the deposition of vitamin E in peri-
pheral tissues and tissues rich in LDL receptors (discussed
below).
3.5.1. Liver phenols. Numerous in vivo studies have shown
the capacity of some phenolic compounds to protect
α-tocopherol from oxidation in LDL.60–62 So, the increase of
the LDL phenolic content could account for the increase of the
resistance of LDL to oxidation, and the decrease of the in vivo
oxidized LDL. The tocopherol in LDL can be acquired by
tissues with LDL receptors, the liver being one of the tissues
with the highest LDL receptors.42
In the present study, the average concentration (nmol g−1
liver) of the main phenolic metabolites whose concentrations
in the liver increased after the dietary phenol supplementation
compared with the control group is shown in Table 2, and the
proposed metabolic pathways of the olive and thyme phenols
are shown in Fig. 4. In contrast to that observed in the muscle
(see below), fewer metabolites derived from olive phenols and
more metabolites derived from thyme phenols were detected
in the liver. The main metabolites quantified from olive
phenols in the liver were hydroxytyrosol-3-O-sulphate (phase II
metabolite) and homovanillic derivatives (mainly homovanillic
acid glucuronide), as obtained in our previous study.41
Nevertheless, the concentration of hydroxytyrosol-3-O-sulphate
detected in rat livers in the present study was lower than that
Fig. 3 Total α-tocopherol content in faeces for each treatment, separated by gender for each treatment (mean ± SD). C (control), OLE (oleuropein),
SEC (secoiridoids), HT (hydroxytyrosol), SEC + T (secoiridoids + thyme), T (thyme). Statistically significant differences by gender for each treatment:
***(P < 0.01). Statistically significant differences by treatment compared to the control: ‡(P < 0.05), ‡‡(P < 0.025), ‡‡‡(P < 0.01).
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reported in our previous study after the acute intake of a single
dose of olive phenolic extract (3 g kg−1 rat weight) dispersed in
water and administered by intragastric gavage. The differences
between the two studies could be related to the phenol dose
and the manner in which it was administered. In the present
study, the phenol was administered by supplementing the diet
(21 days) at a low daily dose (5 mg per kg rat weight per day),
instead of an acute intake, resulting in a lower accumulation
of phenolic metabolites in the liver. In addition, the tissue per-
fusion with isotonic solution performed to remove the remain-
ing blood irrigating tissues after sacrifice of the rats could also
explain this fact.
Thymol sulphate and thymol glucuronide were the main
metabolites related to the thyme detected in the liver, which
are in agreement with the literature.38,63–65 Furthermore,
p-cymene-diol glucuronide was detected in the T group
(Table 2) and this is a good biomarker of thyme phenols, pro-
viding a good indication of thyme phenolic exposure similar to
that observed in human plasma after the intake of a thyme
phenol-enriched olive oil.38 Similar to what was observed to a
lesser extent in the muscle (see the next section), sexual
dimorphism for some metabolites was noted, favouring the
female gender (Table 2).
3.5.2. Muscle tissue phenols. The average concentration
(nmols g−1 muscle) of the main phenolic metabolites whose
concentrations in the muscle increased after the phenol sup-
plementation of the diet related to the control group is shown
in Table 2. In contrast to what was observed with the
α-tocopherol, after the sustained diet supplementation with
different phenols (olive and/or thyme), all experimental groups
showed a phenolic deposition in muscle, therefore demon-
strating its bioavailability. The main phenolic metabolites
related to olive were hydroxytyrosol phase-II metabolites
(hydroxytyrosol-3-O-sulphate and hydroxytyrosol-acetate sul-
phate) and homovanillic derivatives (homovanillic acid glucur-
onide and homovanillic alcohol sulphate) (Fig. 4) which are
derived from homovanillic alcohol which, in turn, comes from
hydroxytyrosol metabolism.65 In relation to the main metab-
olites related to thyme, thymol sulphate showed the largest
increase, after sustained dietary supplementation, jointly with
hydroxyphenilpropionic acid sulphate and thymol glucuronide
(Table 2), similar to what was observed after the sustained
intake of olive oil enriched with olive and thyme phenols.32
Sexual dimorphism has been detected in some phenolic com-
pounds favouring female rats (Table 2). This phenomenon was
detected in the SEC and HT group for metabolites derived
from olive and in the SEC + T group for the metabolites
derived from thyme.
Finally, taking into account the α-tocopherol concentration
in the muscle (Fig. 2) and the phenolic metabolites detected in
it (Table 1), the SEC + T and T groups showed higher accumu-
lation of phenol metabolites (mainly due to thymol sulphate)
Table 2 Main phenolic metabolites (mean±SD) whose concentrations increased, expressed in nmol g−1 fresh tissue, before (control) and after the
intake of HT (hydroxytyrosol), SEC (secoiridoids), OLE (oleuropein), SEC + T (secoiridoids + thyme), and T (thyme)
Control HT SEC OLE SEC + T T
Muscle Tissue (nmol g−1 muscle)
Hydroxytyrosol 3-O-sulphate 0.7 ± 0.6 1.0 ± 0.9‡ 2.2 ± 1.2** ‡‡‡ 2.0 ± 0.7‡‡‡ 0.8 ± 0.6 n.d.
Homovanillic acid sulphate 0.2 ± 0.1 n.d. 1.6 ± 0.8 0.9 ± 0.8‡‡ n.d. n.d.
Homovanillic acid glucuronide 0.4 ± 0.2 1.3 ± 0.2‡‡ 2.4 ± 1.1** ‡‡‡ 1.5 ± 0.2‡‡‡ 1.4 ± 0.1‡‡‡ n.d.
Oleuropein n.d. n.d. 0.3 ± 0.2 0.5 ± 0.4‡‡‡ n.d. n.d.
Homovanillic alcohol sulphate n.d. 0.6 ± 0.4* 2.1 ± 1.1** ‡‡‡ 1.6 ± 0.5‡‡‡ n.d. n.d.
Hydroxytyrosol acetate sulphate n.d. n.d. 1.3 ± 1.2‡‡‡ 0.9 ± 0.8‡‡ 0.7 ± 0.5 n.d.
Coumaric acid sulphate 0.3 ± 0.2 n.d. n.d. n.d. 0.7 ± 0.2‡‡‡ 1.4 ± 0.3‡‡‡
Thymol sulphate n.d. n.d. n.d. n.d. 39.7 ± 25.3* ‡‡ 104 ± 72.6‡‡‡
Hydroxyphenylpropionic acid sulphate n.d. n.d. n.d. n.d. 6.7 ± 2.8* ‡‡‡ 25.9 ± 16.0‡‡‡
Thymol glucuronide n.d. n.d. n.d. n.d. 1.1 ± 1.1* ‡‡‡ 2.54 ± 1.4‡‡‡
Liver Tissue (nmol g−1 liver)
Hydroxytyrosol 3-O-sulphate 1.6 ± 0.2 2.6 ± 1.3‡‡‡ 3.0 ± 1.3‡‡‡ 2.0 ± 0.5‡‡‡ 1.2 ± 0.8‡‡ n.d.
Homovanillic alcohol sulphate 0.2± 0.0 0.3 ± 0.2‡‡ 0.6 ± 0.3‡‡‡ 0.2 ± 0.2 1.2 ± 0.7** ‡‡‡ n.d.
Homovanillic acid glucuronide 2.7 ± 0.8 3.4 ± 1.0‡‡‡ 2.8 ± 1.1‡‡‡ 3.8 ± 1.0‡‡‡ 0.8 ± 0.6 n.d.
Oleuropein n.d. n.d. 0.2 ± 0.0* ‡‡‡ 0.2 ± 0.1* ‡‡‡ n.d. n.d.
Coumaric acid sulphate n.d. n.d. n.d. n.d. 2 ± 0.8‡‡‡ 3.0 ± 1.8** ‡‡‡
Hydroxyphenylpropionic acid sulphate n.d. n.d. n.d. n.d. 9.1 ± 7.2‡‡‡ 14.9 ± 10.0** ‡‡‡
Caffeic acid sulphate n.d. n.d. n.d. n.d. 0.4 ± 0.3** ‡‡‡ 1.7 ± 0.6‡‡‡
Ferulic acid sulphate n.d. n.d. n.d. n.d. 0.6 ± 0.3‡‡‡ 0.7 ± 0.6‡‡‡
Coumaric acid glucuronide n.d. n.d. n.d. n.d. 0.7 ± 0.1‡‡‡ 0.8 ± 0.1‡‡‡
Thymol sulphate n.d. n.d. n.d. n.d. 10.5 ± 9.4‡‡‡ 23.0 ± 13.6‡‡‡
Thymol glucuronide n.d. n.d. n.d. n.d. 0.6 ± 0.3 2.0 ± 2.0‡‡‡
p-Cymene diol glucuronide n.d. n.d. n.d. n.d. n.d. 1.7 ± 1.3‡‡‡
Hydroxyphenylacetic acid 0.01 ± 0.00 n.d. n.d. n.d. 4.7 ± 2.2‡‡‡ 5.6 ± 4.1‡‡‡
Dihydroxyphenylpropionic acid 0.04 ± 0.02 n.d. n.d. n.d. 0.4 ± 0.2‡‡ 1.2 ± 1.0‡‡‡
Statistically significant difference by gender for each treatment: *(P < 0.05), **(P < 0.025). Statistically significant difference by treatment com-
pared to the control: ‡(P < 0.05), ‡‡(P < 0.025), ‡‡‡(P < 0.01). n.d.: not detected.
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and a higher mean α-tocopherol concentration, although it
was not large enough to be statistically significant.
4. Conclusions
In summary, giving Wistar rats a sustained dietary supplemen-
tation (5 mg per kg rat weight per day) for 21 days demon-
strated the ability of some of the olive (OLE and HT) and
thyme (T) phenolic compounds to maintain higher levels of
α-tocopherol in the female liver, although all diets supplied
the same daily dose of α-tocopherol. In addition, a synergic
effect between the olive phenols and thyme (SEC + T) was
observed. In general, no clear relationship was observed
between the increase in the α-tocopherol concentration in the
liver and a lower concentration of α-tocopherol in the faeces,
indicating a higher efficacy in the α-tocopherol accumulation in
the liver that could be related to the dietary supplementation
with phenolic compounds. Polyphenols are thus expected to act
at the water–lipid interface at the liver tissue level and may be
involved in the oxidation regeneration pathway of vitamin
E. Nevertheless, in order to find out more features about in vivo
vitamin E regeneration orchestrated by polyphenols it is necess-
ary to perform future analysis more complex in order to certify/
amplify the biological fact presented in this preliminary study.
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Fig. 4 Proposed metabolic pathways of the main metabolites detected in the study.
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